Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARTIZA DOTRES-MARTINEZ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1447527254
CMS profile
660871
Location
PALM BAY, FL

General Payments · PY2018–2024

$4,302.97

  • Reported across 262 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$610.13

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $610.13 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $218.32 15
GlaxoSmithKline, LLC. $93.60 5
Acerta Pharma LLC $71.81 4
Bayer HealthCare Pharmaceuticals Inc. $65.49 3
Amgen Inc. $64.82 4
Abbott Laboratories $43.91 2
PFIZER INC. $28.79 1
Exact Sciences Corporation $23.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $39.28 2
PY2019 $781.06 52
PY2020 $305.28 19
PY2021 $462.03 26
PY2022 $956.22 63
PY2023 $1,148.97 65
PY2024 $610.13 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.94 04/17/2024 Food and Beverage Undisputed 01/23/2026 1125071585 CMS
Abbott Laboratories $22.97 11/13/2024 Food and Beverage Undisputed 01/23/2026 1125071587 CMS
Amgen Inc. $14.24 07/16/2024 Food and Beverage Undisputed 01/23/2026 1117241469 CMS
Amgen Inc. $17.96 09/25/2024 Food and Beverage Undisputed 01/23/2026 1111565595 CMS
Amgen Inc. $14.17 10/21/2024 Food and Beverage Undisputed 01/23/2026 1111565597 CMS
Amgen Inc. $18.45 11/18/2024 Food and Beverage Undisputed 01/23/2026 1111565599 CMS
AstraZeneca Pharmaceuticals LP $18.40 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104206007 CMS
AstraZeneca Pharmaceuticals LP $15.70 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104653879 CMS
AstraZeneca Pharmaceuticals LP $15.22 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105302541 CMS
AstraZeneca Pharmaceuticals LP $22.49 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105656622 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.30 01/17/2024 Food and Beverage Undisputed 01/23/2026 1086200080 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.90 02/15/2024 Food and Beverage Undisputed 01/23/2026 1086225374 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.29 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086115754 CMS
Exact Sciences Corporation $23.39 05/23/2024 Food and Beverage Undisputed 01/23/2026 1114640229 CMS
GlaxoSmithKline, LLC. $22.75 01/26/2024 Food and Beverage Undisputed 01/23/2026 1116660411 CMS
GlaxoSmithKline, LLC. $21.45 03/27/2024 Food and Beverage Undisputed 01/23/2026 1116250308 CMS
GlaxoSmithKline, LLC. $16.54 08/13/2024 Food and Beverage Undisputed 01/23/2026 1116431847 CMS
GlaxoSmithKline, LLC. $17.30 11/15/2024 Food and Beverage Undisputed 01/23/2026 1116377374 CMS
GlaxoSmithKline, LLC. $15.56 12/05/2024 Food and Beverage Undisputed 01/23/2026 1116573918 CMS
Novo Nordisk Inc $12.00 01/04/2024 Food and Beverage Undisputed 01/23/2026 1097743181 CMS
Novo Nordisk Inc $10.00 01/18/2024 Food and Beverage Undisputed 01/23/2026 1096728560 CMS
Novo Nordisk Inc $15.27 02/08/2024 Food and Beverage Undisputed 01/23/2026 1096990257 CMS
Novo Nordisk Inc $14.81 02/22/2024 Food and Beverage Undisputed 01/23/2026 1097424542 CMS
Novo Nordisk Inc $17.85 03/18/2024 Food and Beverage Undisputed 01/23/2026 1096860505 CMS
Novo Nordisk Inc $14.95 05/02/2024 Food and Beverage Undisputed 01/23/2026 1096648420 CMS
Novo Nordisk Inc $5.54 05/16/2024 Food and Beverage Undisputed 01/23/2026 1096916230 CMS
Novo Nordisk Inc $20.98 05/31/2024 Food and Beverage Undisputed 01/23/2026 1096734321 CMS
Novo Nordisk Inc $14.14 07/08/2024 Food and Beverage Undisputed 01/23/2026 1096960550 CMS
Novo Nordisk Inc $17.84 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097388615 CMS
Novo Nordisk Inc $14.30 09/27/2024 Food and Beverage Undisputed 01/23/2026 1097436752 CMS
Novo Nordisk Inc $4.68 10/02/2024 Food and Beverage Undisputed 01/23/2026 1096890204 CMS
Novo Nordisk Inc $16.44 11/13/2024 Food and Beverage Undisputed 01/23/2026 1097188809 CMS
Novo Nordisk Inc $26.19 11/26/2024 Food and Beverage Undisputed 01/23/2026 1097173704 CMS
Novo Nordisk Inc $13.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 1096863735 CMS
PFIZER INC. $28.79 11/06/2024 Food and Beverage Undisputed 01/23/2026 1131054254 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.